Client Story
hg medical
hg medical is a vertically integrated contract manufacturer for orthopedic implants which supports large medical technology companies in the technical implementation of product innovations, development services and individual customer solutions.
Within a competitive M&A process, hg medical group was up for sale by the former shareholders with hg Darco Group LLC as the former majority shareholder. We were mandated to structure the financing solution and to manage a competitive debt financing process in order to secure optimal financing conditions for the transaction.
Debt and Capital Advisory
Healthcare and Life Sciences
Zentrale Ergebnisse
Optimal acquisition financing conditions
during a competitive financing process secured.
Future organic and inorganic growth
of hg medical group enabled.
Successful acquisition
of hg medical group by Nord Holding during a competitive M&A process.
Scroll down
The challenge
- Within a competitive M&A process hg medical group was up for sale by the former shareholders with hg Darco Group LLC as the former majority shareholder.
- Within the transaction the German hg medical GmbH and US based hg medical LLC have jointly been sold as hg medical group, now majority-owned by Nord Holding and its related funds.
- Due to the competitive and short-timed M&A process and the cross- border business model of the group with significant US sales, demands for an optimal acquisition financing solution were complex.
- Therefore, we were mandated to structure the financing solution and to manage a competitive debt financing process in order to secure optimal financing conditions for the transaction.
The solution
- Structured an optimal acquisition financing solution and managed competitive debt financing process.
- Ensured financing solution is well-fitted to business model.
- Lender education and management of due diligence process to ensure bankable due diligence reports, tailor-made to specific needs of acquisition lenders.
- Secured financing in a short-timed process, meeting tough timelines.
- Provided a competitive edge to Nord Holding during acquisition process by best-market terms financing package, enabling Nord Holding to in turn provide most attractive acquisition bid during M&A process.
They have played a vital role in providing a tailored financing solution in a complex cross-border transaction. We have been very pleased with the ongoing support and deep expertise the team has showcased throughout the entire, tight-knit process. We want to thank the team and are looking forward to future engagements.Member of the Investment Committee of hg medical
Passion for resultsWhat our
client says
Expertise we provided
BEREIT FÜR DIE ZUKUNFT?Lassen Sie uns gemeinsam herausfinden, wie wir Sie unterstützen können!
Was gibt es Neues?Das könnte Sie auch interessieren...
Insight
Studie
StresstestLiquiditätsentwicklung:Resilienz durchvorausschauende Steuerung
Unternehmen sind heute verstärkt unvorhergesehenen Risiken ausgesetzt – von physischen Lieferengpässen über Cyberangriffe bis hin zu geopolitischen Handelskonflikten. Diese Volatilität hat unmittelbare Auswirkungen auf die Supply Chain und kann die Finanzlage massiv beeinträchtigen. Unsere aktuelle Simulation belegt jedoch, dass Vorbereitung den entscheidenden Unterschied macht: Durch ein vorausschauendes Steuerungsmodell und erhöhte Transparenz lässt sich die Cash-Position in Krisenszenarien um bis zu über 100 % verbessern. Um ihre Wettbewerbsfähigkeit und Liquidität langfristig zu sichern, müssen Unternehmen präventive Maßnahmen ergreifen, die von strategischer Planung bis hin zu operativen Eingriffen wie dem Inbound-Freeze reichen.
Deal Announcement
Fortlane Partners advised TricorBraun
Fortlane Partners advised TricorBraun on its acquisition of European packaging providers Euroglas and Glaspack with a Commercial Due Dilligence
Insight
Studie
Kapitaleffizienz in der Metall- & Rohstoff-industrie
In der Metall- und Rohstoffindustrie haben steigende Energie- und Materialkosten, intensiver internationaler Wettbewerbsdruck und volatile Absatzmärkte die Margen seit 2020 deutlich unter Druck gesetzt. Die Kapitaleffizienz ist in diesem Zeitraum um mehr als 30 % gesunken, da es vielen Unternehmen nicht gelungen ist, sinkende Profitabilität durch gezieltes Cashflow- und Working-Capital-Management zu kompensieren. Um ihre Kapitaleffizienz zu stabilisieren, müssen Unternehmen verstärkt an beiden Stellhebeln ansetzen – Profitabilität und Kapitalbindung – und diese in einem integrierten Projektansatz gemeinsam optimieren.